# NICE Ltd.: Form 20-F for the period ended Dec 31, 2022

- Company: [NICE Ltd.](/companies/nice.md) (CIK 1003935)
- Form: 20-F
- Filed: 2023-03-30
- Accepted by EDGAR: Mar 30, 2023, 07:20 ET
- Period: 2022-12-31
- Accession: 0001003935-23-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1003935/000100393523000005/nice-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1003935/000100393523000005/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $2.18bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $683.7m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2022-01-01 to 2022-12-31 | $1.50bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2022-01-01 to 2022-12-31 | $306.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | $335.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-01-01 to 2022-12-31 | $1.1m | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $79.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | $265.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | $4.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | $4.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2022-01-01 to 2022-12-31 | 66,465,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | $479.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $31.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2022-01-01 to 2022-12-31 | $144.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-12-31 | $529.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $2.42bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $4.85bn | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $1.14bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-12-31 | $455.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-12-31 | $209.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-12-31 | $3.04bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2022-12-31 | 63,634,991 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1003935/000100393523000005/nice-20221231.htm

Filed Mar 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001003935-23-000005. Last ingested by Listed: Nov 5, 2026, 14:06 ET. No prices; not investment advice.